Complete Filing Data
Viridian Therapeutics, Inc.DE reported Net Income Loss of -$342.60 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Viridian Therapeutics, Inc.DE did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$342.6M | -$269.9M | -$237.7M | -$129.9M | -$79.4M | -$110.7M | -$41.9M | -$32.7M | -$26.5M | -$17.3M | -$11.3M | -$7.9M | -$2.2M |
| Revenue * | $70.8M | $302.0K | $314.0K | $1.8M | $3.0M | $1.1M | $4.5M | $8.4M | $4.0M | $3.5M | $2.5M | $4.3M | $4.3M |
| General And Administrative Expense | $61.1M | $95.0M | $35.2M | $25.8M | $13.3M | $11.6M | $11.0M | $10.9M | $6.8M | $7.7M | $6.9M | $1.4M | |
| Operating Income Loss | -$363.4M | -$299.0M | -$254.5M | -$134.3M | -$79.7M | -$110.4M | -$42.0M | -$33.1M | -$26.5M | -$17.0M | -$11.2M | -$6.9M | -$197.0K |
| Operating Expenses | $434.2M | $299.3M | $254.8M | $136.1M | $82.7M | $111.4M | $46.4M | $41.5M | $30.5M | $20.5M | $13.7M | $11.2M | $4.5M |
| Research And Development Expense | $34.8M | $30.4M | $19.6M | $13.7M | $1.0M | $347.0K | $225.0K | ||||||
| Nonoperating Income Expense | $20.8M | $29.1M | $16.7M | $4.4M | $315.0K | $173.0K | $941.0K | $1.3M | $403.0K | $39.0K | |||
| Net Income Loss Available To Common Stockholders Basic | -$79.4M | -$110.7M | -$41.9M | -$32.7M | -$26.5M | -$17.3M | -$7.9M | -$2.4M | |||||
| Comprehensive Income Net Of Tax | -$342.1M | -$270.3M | -$237.0M | -$130.1M | -$79.6M | -$110.7M | -$41.9M | -$32.7M | -$26.5M | ||||
| Research And Development Expense Excluding Acquired In Process Cost | $338.9M | $238.3M | $159.8M | $100.9M | $56.9M | $28.3M | $34.8M | ||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | -$233.0K | -$149.0K | -$8.0K | $3.0K | -$3.0K | $0.00 | |||||||
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | -$348.0K | $728.0K | -$233.0K | -$149.0K | |||||||||
| Selling And Marketing Expense | $1.7M | $2.6M | $717.0K | $349.0K | |||||||||
| Interest Expense | $95.0K | $141.0K | $1.0M | $2.0M | |||||||||
| Cost Of Revenue | $2.5M | $2.5M | $3.4M | $2.8M | |||||||||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $457.0K | -$348.0K | $728.0K | -$233.0K | -$149.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$34.6M | -$100.7M | -$86.9M | -$76.7M | -$65.0M | -$48.5M | -$47.7M | -$55.1M | -$68.2M | -$28.9M | -$29.5M | -$25.7M | -$14.0M | -$18.0M | -$18.5M | -$5.5M | -$6.4M | -$8.0M | -$10.1M | -$11.2M | -$8.9M | -$11.6M | -$10.3M | -$9.0M | -$8.7M | -$4.7M | -$6.4M | -$5.8M | -$7.3M | -$7.0M | -$6.0M | -$4.2M | -$3.5M | -$3.6M | -$3.2M | -$2.6M | -$2.6M | -$1.6M | -$3.3M | -$706.0K | -$939.6K | -$629.7K |
| Revenue * | $70.6M | $75.0K | $72.0K | $86.0K | $72.0K | $72.0K | $72.0K | $72.0K | $98.0K | $1.2M | $256.0K | $216.0K | $208.0K | $1.1M | $1.5M | $0.00 | $168.0K | $828.0K | $880.0K | $695.0K | $2.5M | $372.0K | $476.0K | $944.0K | $2.2M | $4.8M | $1.2M | $1.6M | $718.0K | $462.0K | $509.0K | $936.0K | $1.1M | $917.0K | $501.0K | $734.0K | $645.0K | $1.3M | $1.3M | $1.1M | $983.6K | $1.1M |
| General And Administrative Expense | $24.3M | $20.2M | $17.1M | $14.4M | $16.1M | $15.0M | $20.9M | $19.3M | $21.8M | $8.9M | $8.1M | $8.4M | $6.2M | $6.5M | $6.2M | $2.3M | $2.7M | $2.7M | $2.5M | $2.9M | $2.9M | $3.4M | $2.7M | $2.7M | $2.7M | $3.0M | $2.5M | $2.5M | $2.6M | $3.3M | $2.5M | $2.1M | $1.2M | $992.0K | $2.0M | $1.8M | $2.0M | $1.8M | $2.9M | $426.0K | $435.5K | $470.4K |
| Operating Income Loss | -$40.0M | -$106.8M | -$93.9M | -$83.5M | -$72.2M | -$55.9M | -$51.2M | -$59.3M | -$72.5M | -$29.8M | -$29.6M | -$25.9M | -$14.1M | -$18.0M | -$18.5M | -$5.4M | -$6.4M | -$8.0M | -$11.2M | -$8.9M | -$11.7M | -$9.2M | -$8.9M | -$4.6M | -$5.9M | -$7.4M | -$6.9M | -$4.1M | -$3.5M | -$3.5M | -$3.1M | -$2.5M | -$2.6M | -$1.6M | -$2.8M | -$167.0K | -$311.7K | -$60.4K | ||||
| Operating Expenses | $110.6M | $106.8M | $93.9M | $83.6M | $72.3M | $56.0M | $51.3M | $59.3M | $72.6M | $31.0M | $29.8M | $26.1M | $14.3M | $19.1M | $20.0M | $5.4M | $6.5M | $8.8M | $11.9M | $11.5M | $12.1M | $10.1M | $11.0M | $9.4M | $7.5M | $8.1M | $7.4M | $5.0M | $4.6M | $4.5M | $3.6M | $3.2M | $3.3M | $2.9M | $4.1M | $1.3M | $1.3M | $1.2M | ||||
| Research And Development Expense | $3.1M | $3.8M | $6.1M | $8.4M | $9.0M | $8.6M | $8.8M | $8.2M | $7.4M | $8.4M | $6.4M | $5.0M | $5.0M | $5.5M | $4.1M | $3.9M | $3.0M | $3.4M | $3.5M | $253.0K | $194.0K | $100.0K | $105.0K | $128.0K | $35.0K | $46.6K | $22.8K | |||||||||||||||
| Nonoperating Income Expense | $5.4M | $6.0M | $7.0M | $6.8M | $7.2M | $7.4M | $3.6M | $4.2M | $4.3M | $880.0K | $73.0K | $196.0K | $91.0K | $34.0K | $55.0K | $9.0K | $33.0K | $95.0K | $204.0K | $275.0K | $339.0K | $362.0K | $361.0K | $167.0K | $113.0K | $102.0K | $30.0K | $7.0K | $9.0K | $7.0K | ||||||||||||
| Net Income Loss Available To Common Stockholders Basic | -$25.7M | -$14.0M | -$18.0M | -$18.5M | -$5.5M | -$6.4M | -$8.0M | -$10.1M | -$11.2M | -$8.9M | -$11.6M | -$10.3M | -$9.0M | -$8.7M | -$4.7M | -$6.4M | -$5.8M | -$7.3M | -$7.0M | -$6.0M | -$4.2M | -$3.5M | -$3.6M | -$1.6M | -$3.3M | -$940.0K | -$630.0K | |||||||||||||||
| Comprehensive Income Net Of Tax | -$34.3M | -$100.9M | -$86.7M | -$75.2M | -$65.2M | -$49.2M | -$47.6M | -$55.1M | -$67.9M | -$28.8M | -$29.6M | -$26.5M | -$14.0M | -$18.0M | -$18.5M | -$5.5M | -$6.4M | -$8.0M | -$11.2M | -$8.9M | -$11.6M | -$9.0M | -$8.7M | -$4.7M | -$5.8M | -$7.3M | ||||||||||||||||
| Research And Development Expense Excluding Acquired In Process Cost | $86.3M | $86.6M | $76.8M | $69.2M | $56.2M | $40.9M | $30.4M | $40.1M | $50.7M | $22.1M | $21.7M | $17.7M | $8.1M | $12.6M | $13.8M | $3.1M | $3.8M | $6.1M | ||||||||||||||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | $9.0K | $9.0K | -$13.0K | $0.00 | $0.00 | $0.00 | -$8.0K | $9.0K | $5.0K | -$10.0K | $4.0K | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $255.0K | $1.5M | -$176.0K | -$705.0K | $109.0K | $1.0K | $216.0K | $137.0K | -$142.0K | -$778.0K | $9.0K | $9.0K | -$13.0K | |||||||||||||||||||||||||||||
| Selling And Marketing Expense | $373.0K | $555.0K | $510.0K | $796.0K | $574.0K | $434.0K | $169.0K | $66.0K | $66.0K | $99.9K | $67.1K | |||||||||||||||||||||||||||||||
| Interest Expense | $23.0K | $23.0K | $23.0K | $24.0K | $72.0K | $22.0K | $4.0K | $478.0K | $539.0K | $568.0K | $479.3K | |||||||||||||||||||||||||||||||
| Cost Of Revenue | $599.0K | $628.0K | $629.0K | $577.0K | $678.0K | $760.0K | $900.0K | $954.0K | $731.0K | $713.2K | $603.1K | |||||||||||||||||||||||||||||||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $294.0K | -$176.0K | $255.0K | $1.5M | -$176.0K | -$705.0K | $109.0K | $1.0K | $216.0K | $137.0K | -$142.0K | -$778.0K | $9.0K | $9.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $722.2M | $671.6M | $442.0M | $395.1M | $187.7M | $120.0M | $15.8M | $51.3M | $38.5M | -$61.9M | -$45.3M | $6.0M | -$23.9M |
| Prepaid Expense And Other Assets Current | $19.6M | $20.9M | $9.0M | $6.5M | $2.7M | $2.0M | $2.9M | $2.9M | $3.0M | $1.8M | $321.0K | $399.0K | $445.0K |
| Liabilities Current | $70.7M | $47.9M | $26.6M | $33.3M | $13.6M | $10.7M | $10.2M | $6.7M | $3.9M | $6.9M | $2.5M | $2.0M | $27.3M |
| Assets Current | $894.2M | $738.5M | $486.5M | $431.2M | $200.2M | $129.6M | $29.7M | $65.4M | $51.9M | $23.9M | $11.7M | $6.8M | $2.1M |
| Assets | $899.4M | $742.4M | $490.4M | $435.1M | $203.7M | $131.3M | $30.3M | $66.1M | $52.5M | $24.8M | $12.9M | $8.1M | $3.7M |
| Property Plant And Equipment Net | $1.2M | $1.2M | $1.7M | $1.3M | $375.0K | $309.0K | $523.0K | $727.0K | $563.0K | $625.0K | $1.2M | $1.2M | $928.0K |
| Liabilities And Stockholders Equity | $899.4M | $742.4M | $490.4M | $435.1M | $203.7M | $131.3M | $30.3M | $66.1M | $52.5M | $24.8M | $12.9M | $8.1M | $3.7M |
| Retained Earnings Accumulated Deficit | -$1.34B | -$995.9M | -$725.9M | -$488.2M | -$358.3M | -$278.9M | -$168.2M | -$126.3M | -$93.6M | -$67.1M | -$18.0M | -$6.6M | |
| Common Stock Value | $1.0M | $810.0K | $540.0K | $414.0K | $239.0K | $42.0K | $23.0K | $308.0K | $226.0K | $8.0K | $7.0K | $38.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $212.4M | $99.6M | $102.8M | $155.6M | $42.3M | $45.9M | $24.8M | $32.6M | $47.4M | ||||
| Accrued Liabilities Current | $62.0M | $45.7M | $24.1M | $18.8M | $11.0M | $9.7M | $5.1M | $3.9M | $3.0M | $3.9M | $1.0M | $361.0K | $271.0K |
| Accounts Payable Current | $8.7M | $2.1M | $2.2M | $14.2M | $2.3M | $670.0K | $1.1M | $571.0K | $906.0K | $1.0M | $242.0K | $255.0K | $100.0K |
| Other Liabilities Noncurrent | $2.3M | $2.3M | $989.0K | $1.2M | $1.2M | $43.0K | $0.00 | $66.0K | $152.0K | $0.00 | $24.0K | $109.0K | |
| Interest And Debt Expense | $1.8M | $486.0K | $3.0K | $508.0K | $835.0K | $873.0K | $383.0K | $326.0K | |||||
| Operating Lease Right Of Use Asset | $2.4M | $2.2M | $1.7M | $1.6M | $1.7M | $478.0K | |||||||
| Cash And Cash Equivalents At Carrying Value | $22.1M | $21.2M | $5.1M | $209.0K | |||||||||
| Liabilities | $177.3M | $70.8M | $48.4M | $40.0M | $16.0M | $11.2M | $14.5M | $14.8M | $14.0M | $9.7M | |||
| Other Assets Noncurrent | $1.5M | $501.0K | $604.0K | $982.0K | $1.5M | $1.0K | $0.00 | $50.0K | $50.0K | $258.0K | |||
| Accounts Receivable Net Current | $24.0K | $1.5M | $20.0K | $394.0K | $1.1M | $994.0K | |||||||
| Accretion Amortization Of Discounts And Premiums Investments | $6.8M | $15.7M | $11.5M | $210.0K | -$965.0K | -$56.0K | $432.0K | $416.0K | $0.00 | ||||
| Repayments Of Notes Payable | $0.00 | $10.3M | $2.3M | $0.00 | $4.7M | $333.0K | $42.0K | $61.0K | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $447.0K | -$10.0K | $338.0K | -$390.0K | -$157.0K | -$8.0K | $0.00 | -$3.0K | $0.00 | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $112.8M | -$3.2M | -$52.8M | $113.3M | -$3.6M | $21.1M | -$7.8M | -$14.8M | |||||
| Notes Payable Current | $0.00 | $4.0M | $2.3M | $0.00 | $2.0M | $42.0K | |||||||
| Long Term Notes Payable | $0.00 | $4.3M | $8.0M | $9.9M | $2.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q3 2013 | Q2 2013 | Q4 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $503.0M | $515.2M | $604.5M | $707.5M | $529.3M | $582.5M | $283.6M | $315.9M | $350.5M | $409.0M | $141.9M | $166.6M | $204.6M | $98.9M | $106.0M | $21.0M | $21.2M | $27.0M | $23.2M | $33.4M | $41.0M | $60.7M | $67.7M | $72.7M | $39.0M | $41.3M | $48.0M | $4.7M | $6.4M | $8.3M | $12.6M | $10.9M | $13.1M | $8.5M | ||||||||
| Prepaid Expense And Other Assets Current | $11.0M | $15.4M | $20.6M | $14.1M | $10.3M | $13.5M | $10.7M | $11.9M | $8.6M | $5.6M | $4.3M | $3.4M | $3.6M | $4.1M | $3.1M | $1.8M | $1.7M | $2.2M | $3.4M | $3.8M | $3.2M | $3.8M | $3.8M | $3.4M | $3.0M | $2.5M | $2.4M | $366.0K | $594.0K | $353.0K | $570.0K | $294.0K | $295.0K | $434.9K | $468.9K | |||||||
| Liabilities Current | $50.7M | $52.6M | $33.7M | $41.4M | $36.8M | $26.1M | $23.2M | $28.7M | $29.6M | $25.2M | $21.4M | $14.4M | $14.3M | $16.8M | $16.4M | $7.6M | $6.7M | $8.7M | $10.4M | $9.1M | $6.9M | $6.8M | $4.3M | $4.1M | $6.5M | $6.6M | $7.3M | $2.9M | $2.6M | $2.4M | $2.1M | $2.1M | $2.5M | $2.0M | $2.1M | |||||||
| Assets Current | $571.9M | $578.8M | $657.2M | $767.4M | $581.7M | $626.8M | $323.8M | $346.3M | $382.6M | $437.4M | $166.2M | $179.4M | $217.9M | $115.5M | $121.5M | $32.0M | $32.5M | $38.3M | $38.2M | $48.1M | $54.2M | $75.8M | $81.2M | $86.4M | $46.4M | $49.4M | $56.9M | $6.5M | $8.0M | $9.7M | $13.6M | $11.9M | $14.5M | $8.7M | $9.8M | |||||||
| Assets | $577.1M | $582.3M | $661.0M | $771.9M | $585.7M | $630.4M | $328.8M | $351.5M | $386.6M | $440.6M | $169.8M | $183.2M | $221.2M | $118.2M | $122.8M | $32.8M | $33.5M | $39.1M | $38.8M | $48.8M | $55.0M | $76.6M | $81.9M | $87.0M | $47.1M | $50.0M | $57.8M | $7.5M | $9.0M | $10.8M | $14.8M | $13.1M | $15.7M | $9.5M | $10.7M | |||||||
| Property Plant And Equipment Net | $1.1M | $1.1M | $1.2M | $1.3M | $1.5M | $1.5M | $1.8M | $1.9M | $1.6M | $825.0K | $749.0K | $691.0K | $347.0K | $298.0K | $148.0K | $370.0K | $379.0K | $443.0K | $596.0K | $652.0K | $691.0K | $751.0K | $614.0K | $589.0K | $610.0K | $626.0K | $597.0K | $1.0M | $1.1M | $1.1M | $1.2M | $1.2M | $1.2M | $825.9K | $860.0K | |||||||
| Liabilities And Stockholders Equity | $577.1M | $582.3M | $661.0M | $771.9M | $585.7M | $630.4M | $328.8M | $351.5M | $386.6M | $440.6M | $169.8M | $183.2M | $221.2M | $118.2M | $122.8M | $32.8M | $33.5M | $39.1M | $38.8M | $48.8M | $55.0M | $76.6M | $81.9M | $87.0M | $47.1M | $50.0M | $57.8M | $7.5M | $9.0M | $10.8M | $14.8M | $13.1M | $15.7M | $10.7M | ||||||||
| Retained Earnings Accumulated Deficit | -$1.22B | -$1.18B | -$1.08B | -$916.1M | -$839.4M | -$774.5M | -$659.0M | -$611.4M | -$556.3M | -$442.4M | -$413.5M | -$384.0M | -$329.4M | -$315.3M | -$297.3M | -$188.1M | -$182.7M | -$176.2M | -$158.1M | -$146.8M | -$137.9M | -$116.0M | -$107.0M | -$98.3M | -$87.2M | -$81.4M | -$74.1M | -$25.1M | -$23.2M | -$20.7M | -$15.0M | -$11.8M | -$9.3M | -$31.5M | -$29.9M | |||||||
| Common Stock Value | $822.0K | $817.0K | $816.0K | $792.0K | $639.0K | $638.0K | $437.0K | $436.0K | $431.0K | $402.0K | $285.0K | $272.0K | $194.0K | $86.0K | $72.0K | $571.0K | $531.0K | $531.0K | $312.0K | $310.0K | $309.0K | $308.0K | $306.0K | $302.0K | $219.0K | $215.0K | $214.0K | $108.0K | $108.0K | $107.0K | $106.0K | $78.0K | $75.0K | $37.8K | $37.8K | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $169.6M | $117.3M | $116.2M | $200.3M | $107.7M | $91.6M | $111.6M | $87.1M | $88.5M | $344.2M | $31.3M | $30.9M | $138.9M | $27.7M | $46.5M | $30.1M | $30.6M | $36.1M | $24.9M | $24.0M | $18.2M | |||||||||||||||||||||
| Accrued Liabilities Current | $40.6M | $35.3M | $29.6M | $34.7M | $30.4M | $23.2M | $19.2M | $24.2M | $21.4M | $12.8M | $17.0M | $11.6M | $10.3M | $14.2M | $12.8M | $2.6M | $3.0M | $3.1M | $4.9M | $3.9M | $3.0M | $4.3M | $3.5M | $3.4M | $4.1M | $4.0M | $4.2M | $1.6M | $1.3M | $1.1M | $713.0K | $477.0K | $803.0K | |||||||||
| Accounts Payable Current | $10.1M | $8.5M | $3.9M | $6.3M | $3.1M | $2.7M | $3.7M | $4.1M | $7.9M | $12.2M | $4.1M | $2.5M | $3.7M | $2.4M | $3.4M | $232.0K | $286.0K | $1.6M | $1.6M | $1.2M | $517.0K | $1.2M | $461.0K | $760.0K | $409.0K | $632.0K | $1.1M | $51.0K | $94.0K | $102.0K | $195.0K | $332.0K | $384.0K | |||||||||
| Other Liabilities Noncurrent | $2.6M | $2.1M | $1.9M | $2.2M | $1.6M | $896.0K | $1.3M | $1.5M | $1.0M | $813.0K | $938.0K | $1.1M | $2.3M | $1.2M | $33.0K | $106.0K | $211.0K | $0.00 | $0.00 | $41.0K | $88.0K | $110.0K | $131.0K | $171.0K | $189.0K | $174.0K | $2.0K | $8.0K | $14.0K | $50.0K | $76.0K | $103.0K | ||||||||||
| Interest And Debt Expense | $587.0K | $600.0K | $166.0K | $165.0K | $164.0K | $154.0K | $0.00 | $0.00 | $0.00 | $0.00 | $93.0K | $94.0K | $141.0K | $204.0K | $229.0K | $232.0K | $222.0K | $214.0K | $209.0K | $58.0K | $64.0K | $71.0K | $78.0K | $83.0K | $89.0K | |||||||||||||||||
| Operating Lease Right Of Use Asset | $2.6M | $2.0M | $2.1M | $2.4M | $1.8M | $1.5M | $1.9M | $2.1M | $1.5M | $1.2M | $1.4M | $1.5M | $1.5M | $1.6M | $1.6M | $100.0K | $490.0K | $584.0K | $266.0K | $1.6M | ||||||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $24.9M | $24.0M | $18.2M | $32.6M | $31.7M | $43.4M | $78.1M | $47.4M | $42.8M | $46.3M | $46.3M | $24.6M | $8.4M | $17.0M | $12.1M | $10.4M | $13.3M | $6.4M | $7.7M | $226.3K | $247.1K | $112.5K | ||||||||||||||||||||
| Liabilities | $74.2M | $67.2M | $56.5M | $64.4M | $56.3M | $47.9M | $45.2M | $35.6M | $36.1M | $31.6M | $27.9M | $16.5M | $16.6M | $19.3M | $16.8M | $11.8M | $12.3M | $12.1M | $15.6M | $15.3M | $14.0M | $15.8M | $14.2M | $14.3M | $8.1M | $8.7M | $9.8M | |||||||||||||||
| Other Assets Noncurrent | $1.5M | $506.0K | $489.0K | $853.0K | $659.0K | $555.0K | $1.3M | $1.2M | $982.0K | $1.2M | $1.5M | $1.5M | $1.5M | $97.0K | $1.0K | $1.0K | $1.0K | $0.00 | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $258.0K | ||||||||||||||||
| Accounts Receivable Net Current | $57.0K | $248.0K | $4.0K | $108.0K | $979.0K | $325.0K | $6.0K | $1.4M | $1.2M | $4.8M | $635.0K | $539.0K | $277.0K | $733.0K | $658.0K | $490.0K | $547.0K | $581.0K | $598.0K | $1.5M | $1.4M | |||||||||||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $2.3M | $4.7M | $3.0M | -$274.0K | -$232.0K | $1.0K | $182.0K | $0.00 | ||||||||||||||||||||||||||||||||||
| Repayments Of Notes Payable | $0.00 | $1.0M | $0.00 | $0.00 | $500.0K | $0.00 | ||||||||||||||||||||||||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $363.0K | $69.0K | $245.0K | $932.0K | -$543.0K | -$367.0K | -$64.0K | -$173.0K | -$174.0K | -$940.0K | -$1.1M | -$935.0K | -$3.0K | -$12.0K | -$21.0K | $3.0K | $11.0K | $2.0K | -$6.0K | $4.0K | ||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $16.6M | -$11.2M | -$67.1M | -$11.4M | $592.0K | $11.3M | -$14.4M | |||||||||||||||||||||||||||||||||||
| Notes Payable Current | $4.7M | $3.4M | $4.0M | $4.0M | $4.0M | $3.3M | $1.3M | $289.0K | $2.0M | $2.0M | $2.0M | $10.6K | $10.6K | |||||||||||||||||||||||||||||
| Long Term Notes Payable | $4.1M | $5.4M | $3.4M | $5.3M | $6.2M | $7.1M | $8.9M | $9.8M | $10.0M | $1.4M | $1.9M | $2.3M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $460.0K | $540.0K | $522.0K | $255.0K | $120.0K | $239.0K | $288.0K | $281.0K | $308.0K | $341.0K | $184.0K | $144.0K | $148.0K |
| Net Cash Provided By Used In Operating Activities | -$276.4M | -$232.3M | -$184.2M | -$93.8M | -$54.6M | -$29.8M | -$36.1M | -$26.8M | -$28.2M | -$14.8M | -$6.9M | -$2.2M | -$1.2M |
| Net Cash Provided By Used In Financing Activities | $426.7M | $457.7M | $225.7M | $322.2M | $125.3M | $101.3M | $70.0K | $41.9M | $52.5M | $15.9M | $12.7M | $7.4M | $1.3M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$262.0K | $11.7M | $2.1M | $3.3M | $1.5M | $159.0K | -$126.0K | -$51.0K | $724.0K | $426.0K | -$28.0K | -$191.0K | $65.0K |
| Net Cash Provided By Used In Investing Activities | -$37.6M | -$228.7M | -$94.3M | -$115.1M | -$74.3M | -$50.5M | $28.2M | -$29.9M | $1.0M | -$250.0K | -$95.0K | -$274.0K | $6.0K |
| Payments To Acquire Property Plant And Equipment | $495.0K | $511.0K | $898.0K | $797.0K | $338.0K | $42.0K | $84.0K | $445.0K | $246.0K | $250.0K | $123.0K | $266.0K | $5.0K |
| Share Based Compensation | $44.3M | $42.2M | $67.2M | $19.8M | $14.5M | $3.6M | $4.0M | $3.7M | $2.4M | $198.0K | $3.0M | $4.3M | |
| Proceeds From Issuance Of Common Stock | $63.1M | $69.9M | $15.3M | $291.9M | $114.2M | $0.00 | $2.3M | $44.5M | $13.1M | $6.6M | -$500.0K | ||
| Stock Issued During Period Value Share Based Compensation | $5.3M | $19.3M | $2.8M | $1.0M | $29.0K | $87.0K | $182.0K | $307.0K | $213.0K | ||||
| Increase Decrease In Accrued Liabilities | $16.2M | $21.3M | $4.7M | $7.7M | $1.4M | $5.0M | $1.1M | $791.0K | -$2.2M | $2.2M | |||
| Increase Decrease In Accounts Payable | $6.6M | -$73.0K | -$12.0M | $11.5M | $1.7M | -$426.0K | $525.0K | -$335.0K | -$101.0K | $292.0K | |||
| Increase Decrease In Accounts Receivable | -$99.0K | $84.0K | -$1.4M | $1.4M | $20.0K | -$694.0K | $94.0K | -$202.0K | |||||
| Proceeds From Stock Options Exercised | $12.1M | $5.3M | $19.3M | $2.8M | $1.0M | $0.00 | $87.0K | $182.0K | $307.0K | $213.0K | |||
| Payments Of Stock Issuance Costs | $77.0K | $3.0M | $1.5M | ||||||||||
| Payments To Acquire Available For Sale Securities Debt | $579.3M | $695.1M | $407.9M | $223.3M | $188.4M | $81.8M | |||||||
| Increase Decrease In Inventories | -$123.0K | $8.0K | -$178.0K | $187.0K | |||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $2.0M | $633.0K | $383.0K | -$280.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $117.0K | $145.0K | $105.0K | $40.0K | $30.0K | $25.0K | $33.0K | $57.0K | $64.0K | $68.0K | $100.0K | $100.0K | $73.0K | $100.0K | $100.0K | $69.0K | $100.0K | $100.0K | $73.0K | $100.0K | $100.0K | $81.0K | $45.0K | $34.0K | $36.0K | $36.0K | $37.0K | $38.0K | |||||||
| Net Cash Provided By Used In Operating Activities | -$92.7M | -$45.2M | -$62.0M | -$21.0M | -$11.5M | -$8.5M | -$11.8M | -$7.4M | -$8.2M | -$4.2M | -$1.1M | $85.0K | |||||||||||||||||||||||
| Net Cash Provided By Used In Financing Activities | $9.2M | $177.1M | $8.2M | $738.0K | $1.3M | $17.7M | $218.0K | $38.1M | $39.1M | $0.00 | $9.3M | -$189.0K | |||||||||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$285.0K | $4.5M | $2.1M | $740.0K | $3.6M | -$540.0K | $298.0K | $521.0K | $534.0K | $63.0K | -$104.0K | -$311.0K | |||||||||||||||||||||||
| Net Cash Provided By Used In Investing Activities | $100.1M | -$143.0M | -$13.3M | $8.9M | $10.9M | $2.0M | -$2.8M | -$95.0K | $1.2M | -$105.0K | -$44.0K | ||||||||||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $86.0K | $0.00 | $115.0K | $179.0K | $15.0K | $0.00 | $37.0K | $95.0K | $44.0K | $105.0K | $44.0K | ||||||||||||||||||||||||
| Share Based Compensation | $10.2M | $12.7M | $15.2M | $4.7M | $3.2M | $664.0K | $1.0M | $790.0K | $419.0K | $42.0K | $708.0K | $703.7K | $2.9M | ||||||||||||||||||||||
| Proceeds From Issuance Of Common Stock | $186.3M | $0.00 | $19.8M | $138.0K | $40.7M | $0.00 | $9.3M | $6.1M | -$274.0K | ||||||||||||||||||||||||||
| Stock Issued During Period Value Share Based Compensation | $547.0K | $1.1M | $210.0K | $838.0K | $711.0K | $2.1M | $6.9M | $237.0K | $4.0K | $667.0K | $24.0K | $307.0K | $13.0K | $70.0K | $15.0K | $33.0K | $34.0K | $112.0K | $89.0K | ||||||||||||||||
| Increase Decrease In Accrued Liabilities | -$15.8M | -$894.0K | $2.6M | $483.0K | $3.2M | -$2.2M | -$849.0K | $365.0K | -$1.1M | -$771.0K | |||||||||||||||||||||||||
| Increase Decrease In Accounts Payable | $1.8M | $482.0K | -$6.6M | $31.0K | $2.7M | $410.0K | -$54.0K | -$146.0K | $118.0K | $235.0K | |||||||||||||||||||||||||
| Increase Decrease In Accounts Receivable | -$104.0K | -$18.0K | $3.4M | $257.0K | -$60.0K | -$490.0K | $180.0K | ||||||||||||||||||||||||||||
| Proceeds From Stock Options Exercised | $2.3M | $838.0K | $6.9M | $667.0K | $307.0K | $13.0K | $0.00 | $112.0K | $89.0K | $0.00 | |||||||||||||||||||||||||
| Payments Of Stock Issuance Costs | $10.4M | $0.00 | $0.00 | $1.1M | $4.0K | $1.2M | $0.00 | ||||||||||||||||||||||||||||
| Payments To Acquire Available For Sale Securities Debt | $71.2M | $225.6M | $77.3M | $5.2M | $56.7M | ||||||||||||||||||||||||||||||
| Increase Decrease In Inventories | $82.0K | $151.0K | -$232.0K | ||||||||||||||||||||||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$36.0K | $401.0K | $9.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$5.31 | -$4.05 | -$6.66 | -$31.13 | -$20.04 | -$1.10 | -$1.38 | -$28.21 | -$21.02 | -$3.50 | -$12.23 | ||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 3.6M | 2.1M | 29.6M | 19.2M | 614.0K | 539.5K | 2.3M | 200.0K | |||||
| Common Stock Shares Outstanding | 101.8M | 81.0M | 54.0M | 41.3M | 23.9M | 4.2M | 2.3M | 30.8M | 22.6M | 833.7K | 709.0K | 3.8M | 0.00 |
| Common Stock Shares Issued | 101.8M | 81.0M | 54.0M | 41.3M | 23.9M | 4.2M | 2.3M | 30.8M | 22.6M | 833.7K | 709.0K | 3.8M | 0.00 |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 100.0M | 100.0M | 100.0M | 100.0M | 50.0M | 50.0M | 50.0M |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
| Weighted Average Number Of Diluted Shares Outstanding | 44.8M | 32.1M | 11.9M | 3.6M | |||||||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |||
| Weighted Average Number Of Shares Outstanding Basic | 44.8M | 32.1M | 11.9M | 3.6M | |||||||||
| Earnings Per Share Basic | $-5.31 | $-4.05 | $-6.66 | $-31.13 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.15 | -$1.02 | -$0.79 | -$1.09 | -$1.27 | -$1.61 | -$0.86 | -$1.06 | -$0.98 | -$1.25 | -$2.21 | -$2.91 | -$1.48 | -$1.82 | -$2.65 | -$0.31 | -$0.36 | -$0.29 | -$0.38 | -$0.33 | -$0.29 | -$0.29 | -$0.18 | -$0.29 | -$0.27 | -$0.34 | -$0.60 | -$9.20 | -$6.92 | -$5.88 | -$5.58 | -$0.39 | -$0.33 | -$0.45 | -$0.40 | -$4.73 | -$3.53 | -$4.70 | -$3.15 | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 6.3M | 55.8M | 53.1M | 3.0M | 31.1M | 31.0M | 30.9M | 30.7M | 30.3M | 26.5M | 21.6M | 21.4M | 11.6M | 601.7K | 601.7K | 651.0K | 8.1M | 7.8M | 5.8M | 4.1M | 695.5K | 200.0K | 200.0K | 200.0K | ||||||||||||||||||
| Common Stock Shares Outstanding | 82.2M | 81.7M | 81.6M | 79.2M | 63.9M | 63.8M | 43.7M | 43.6M | 43.1M | 40.2M | 28.5M | 23.9M | 19.4M | 8.6M | 7.2M | 57.1M | 53.1M | 53.1M | 31.2M | 31.0M | 30.9M | 30.8M | 30.6M | 30.2M | 21.9M | 21.5M | 21.4M | 10.8M | 10.8M | 10.7M | 10.6M | 7.8M | 7.5M | 3.8M | 3.8M | |||||||
| Common Stock Shares Issued | 82.2M | 81.7M | 81.6M | 79.2M | 63.9M | 63.8M | 43.7M | 43.6M | 43.1M | 40.2M | 28.5M | 27.2M | 19.4M | 8.6M | 7.2M | 57.1M | 53.1M | 53.1M | 31.2M | 31.0M | 30.9M | 30.8M | 30.6M | 30.2M | 21.9M | 21.5M | 21.4M | 10.8M | 10.8M | 10.7M | 10.6M | 7.8M | 7.5M | 3.8M | 3.8M | |||||||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | |||||||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |||||||
| Weighted Average Number Of Diluted Shares Outstanding | 66.4M | 63.9M | 61.1M | 43.7M | 43.3M | 42.2M | 33.7M | 27.8M | 26.1M | 11.2M | 8.1M | 6.3M | 3.7M | 3.5M | ||||||||||||||||||||||||||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | ||||||||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |||||||||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 66.4M | 63.9M | 61.1M | 43.7M | 43.3M | 42.2M | 33.7M | 27.8M | 26.1M | 11.2M | 8.1M | 6.3M | 3.7M | 3.5M | ||||||||||||||||||||||||||||
| Earnings Per Share Basic | $-1.15 | $-1.02 | $-0.79 | $-1.09 | $-1.27 | $-1.61 | $-0.86 | $-1.06 | $-0.98 | $-1.25 | $-2.21 | $-2.91 | $-1.48 | $-1.82 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $44.3M | $42.2M | $67.2M | $19.8M | $14.5M | $3.6M | $4.0M | $3.7M | $2.4M | $198.0K | $3.0M | $4.3M | |
| Additional Paid In Capital | $1.93B | $1.48B | $960.5M | $741.1M | $412.1M | $218.1M | $183.9M | $177.3M | $131.9M | $5.1M | $28.4M | $12.6M | |
| Stock Issued During Period Value Employee Stock Purchase Plan | $1.1M | $674.0K | $580.0K | $183.0K | $39.0K | $26.0K | $110.0K | $242.0K | $110.0K | ||||
| Interest Paid Net | $2.2M | $1.8M | $886.0K | $293.0K | $0.00 | $267.0K | $511.0K | $489.0K | $446.0K | ||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Paid In Kind Interest | $2.6M | $377.0K | $317.0K | $93.0K | $132.0K | $1.0M | $1.9M | ||||||
| Interest And Other Income | $32.1M | $18.6M | $4.9M | $318.0K | |||||||||
| Issuance Of Stock And Warrants For Services Or Claims | $0.00 | $0.00 | $5.7M | $0.00 | $7.5M | $6.0M | $0.00 | $0.00 | $281.0K | $330.0K | $300.0K | ||
| Amortization Of Stock Issuance Costs | $0.00 | $0.00 | $75.0K | $87.0K | $32.0K | $3.0K | $55.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $11.3M | $10.8M | $10.2M | $8.7M | $11.8M | $12.7M | $13.6M | $12.3M | $15.2M | $4.9M | $4.9M | $4.7M | $4.0M | $3.8M | $3.2M | $615.0K | $623.0K | $664.0K | $874.0K | $1.1M | $1.0M | $968.0K | $984.0K | $790.0K | $419.0K | |||||||||||
| Additional Paid In Capital | $1.53B | $1.51B | $1.50B | $1.43B | $1.17B | $1.16B | $807.3M | $792.1M | $771.7M | $709.8M | $452.7M | $439.2M | $372.3M | $259.8M | $242.3M | $208.6M | $203.3M | $202.7M | $180.9M | $179.9M | $178.6M | $176.4M | $174.3M | $170.7M | $126.0M | $122.5M | $121.8M | $29.7M | $29.6M | $29.0M | $27.5M | $22.7M | $22.3M | $39.0M | $38.3M | |
| Stock Issued During Period Value Employee Stock Purchase Plan | $558.0K | $561.0K | $317.0K | $356.0K | $260.0K | $320.0K | $112.0K | $71.0K | $12.0K | $10.0K | $16.0K | $26.0K | $84.0K | $132.0K | $110.0K | |||||||||||||||||||||
| Interest Paid Net | $448.0K | $452.0K | $112.0K | $0.00 | $61.0K | $136.0K | $112.0K | |||||||||||||||||||||||||||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $0.00 | $0.00 | $5.0M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||
| Paid In Kind Interest | $22.0K | $20.0K | $532.0K | |||||||||||||||||||||||||||||||||
| Interest And Other Income | $6.5M | $7.5M | $7.8M | $7.8M | $7.9M | $4.2M | $4.4M | $4.5M | $1.0M | $227.0K | $196.0K | $91.0K | $34.0K | |||||||||||||||||||||||
| Issuance Of Stock And Warrants For Services Or Claims | $330.0K | |||||||||||||||||||||||||||||||||||
| Amortization Of Stock Issuance Costs | $30.0K | $1.0K | $47.0K | $0.00 |
Most recent annual filing with the SEC: February 26, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.